Stopped: The study has been terminated as the team did not have the amount of positives they were expecting and the CI has got early employment at another Trust and will not be carrying on the project.
To verify the analytical performance of GFAP and UCH-L1 biomarkers marketed by Abbott Diagnostics and to assess diagnostic accuracy of these biomarkers in predicting subarachnoid haemorrhage
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Measures of diagnostic accuracy including sensitivity, specificity, negative predictive value and positive predictive value.
Timeframe: 1 year